Kristi Hawley, DO
Dermatology · Caledonia, MINPI 1821350745
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,662,002 of the $2,195,096 with a category attached, or 75.7%. It is spread thinly across 50 manufacturers, the largest accounting for just 20.4%. Among dermatology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3,427 payments — averaging $640.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$448K
- Sanofi$398K
- AbbVie$315K
- Arcutis Biotherapeutics, Inc.$149K
- Sun Pharmaceutical Industries Inc.$140K
- Incyte Corporation$120K
- plus $625K from 44 others
Across 67 payments — averaging $5307.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$137K
- Sanofi US Services Inc.$73K
- Janssen Research & Development, LLC$64K
- Sun Pharmaceutical Industries Inc.$53K
- AbbVie$28K
- Novartis$524
What the payments were for
- Consulting fees$241,30311%
- Speaking & faculty fees$1,662,00276%
- Travel & lodging$224,64110%
- Food & beverage$65,8673%
- Education$1,2830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,195,096 in reported general payments places this provider in the 95th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 62 | $228,103 |
| XolairOmalizumab | 12 | $38,568 |
| Pimecrolimus | 13 | $2,071 |
| Clobetasol Propionate | 83 | $1,996 |
| Fluorouracil | 29 | $1,730 |
| Dutasteride | 28 | $1,281 |
| Tretinoin | 13 | $1,141 |
| Doxycycline Hyclate | 57 | $862 |
| Metronidazole | 11 | $636 |
| Triamcinolone Acetonide | 69 | $589 |
| Fluconazole | 30 | $561 |
| Ketoconazole | 26 | $474 |
| ValacyclovirValacyclovir Hcl | 20 | $289 |
| Minoxidil | 27 | $162 |
| Hydrocortisone | 27 | $143 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Caledonia
- Linda Stein GoldWest Bloomfield$3.3M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Steven DaveluyDearborn$350K
- Benjamin WorkmanMidland$284K
- Diana WestgateKalamazoo$252K
- Christofer BuattiAuburn Hills$247K
- Davide IacobelliClinton Township$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.